Arora, Satish; Gude, Einar; Sigurdardottir, Vilborg; Mortensen, Svend Aage; Eiskjær, Hans; Riise, Gerdt; Mared, Lena; Bjørtuft, Oystein; Ekmehag, Bjørn; Jansson, Kjell; Simonsen, Svein; Aukrust, Pål; Solbu, Dag; Iversen, Martin; Gullestad, Lars (2012). Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate. Journal of heart and lung transplantation, 31(3), pp. 259-65. New York, N.Y.: Elsevier 10.1016/j.healun.2011.12.010
Full text not available from this repository. (Request a copy)The NOCTET (NOrdic Certican Trial in HEart and lung Transplantation) trial demonstrated that everolimus improves renal function in maintenance thoracic transplant (TTx) recipients. Nevertheless, introduction of everolimus is not recommended for patients with advanced renal failure. We evaluated NOCTET data to assess everolimus introduction amongst TTx recipients with advanced renal failure.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Sigurdardottir, Vilborg |
ISSN: |
1053-2498 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:38 |
Last Modified: |
02 Mar 2023 23:21 |
Publisher DOI: |
10.1016/j.healun.2011.12.010 |
PubMed ID: |
22333403 |
Web of Science ID: |
000300806500006 |
URI: |
https://boris.unibe.ch/id/eprint/15193 (FactScience: 222469) |
Actions (login required)
 |
Edit item |